COVID study examines efficacy of immune regulating drug

Researchers at the University of Cincinnati are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial.

Diseases, Conditions, Syndromes

Both narrowband UVB, psoralen UVA helpful for hand eczema

(HealthDay)—Both psoralen ultraviolet A (PUVA) and narrowband ultraviolet B (NBUVB) improve the severity of chronic palmar hand eczema, according to a pilot study published online Dec. 13 in the British Journal of Dermatology.

page 1 from 5